Exploring New Treatment Options for Alzheimer's Disease

Published date: |
Estimated read time: |
Authored by:
  • AdventHealth Research Institute
Topics:
Care

“The inflammatory changes that lead to neurodegeneration, including Alzheimer’s disease, are critical and unexplored and could provide a new mechanism for achieving meaningful clinical benefit. We need to look beyond the amyloid targeting pathway and identify additional interventions in patients for whom other treatments have not been appropriate or effective. If we can show that troculeucel can improve cognitive function in patients who continue to progress on amyloid targeting therapy, that would be a huge step forward, providing new hope to the millions of people suffering from Alzheimer’s disease.” -- Anita Fletcher, MD, Director of Neuroscience Clinical Research, AdventHealth Neuroscience Institute

On July 10, 2025, Dr. Fletcher worked with NKGen Biotech to administer the first dose of troculeucel (SNK01), an investigative natural killer (NK) cell therapy, to a patient with Alzheimer’s disease who exhibited continued cognitive decline despite ongoing treatment with lecanemab, an amyloid targeting therapy. The treatment was administered under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA). Click below to read more.

Read More

Recent News

News

Alcohol, Marijuana and Type 1 Diabetes:

Whether it's a backyard barbecue, a football game or dinner with friends, alcohol and marijuana are common parts of social life. For people with Type 1 diabetes (T1D), understanding how they affect...

Read Article
News

The Science That Moves Medicine Forward:

Have you ever wondered how breakthrough medicines are developed, how doctors determine the most effective treatments, or how healthcare continues to advance? The answer lies in clinical research—the...

Read Article
News

Advancing Cancer Research Closer to Home

At AdventHealth, we believe research is not separate from care. We believe the advancements made are what allow us to help our patients feel whole. That commitment is reflected in a new collaboration...

Read Article
News

Moving More, Managing Better

For people living with type 1 diabetes, managing blood sugar is rarely simple. It’s a daily balancing act involving insulin, food, physical activity, technology and a constant stream of decisions.

Read Article